Sandbox:AA: Difference between revisions
Jump to navigation
Jump to search
Aysha Aslam (talk | contribs) |
Aysha Aslam (talk | contribs) |
||
Line 159: | Line 159: | ||
Among women the median prevalence of genital warts was 1.1% (range 0.8 to 2.3) across all jurisdictions, compared to 4.0% (range 2.9 to 4.7) for MSM and 4.9% (range 3.3 to 5.5) for MSW. | Among women the median prevalence of genital warts was 1.1% (range 0.8 to 2.3) across all jurisdictions, compared to 4.0% (range 2.9 to 4.7) for MSM and 4.9% (range 3.3 to 5.5) for MSW. | ||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | |||
| colspan="3" style="background: #4479BA; text-align: center;" | {{fontcolor|#FFF|'''For individuals without penicillin allergy'''}} | |||
|+ | |||
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF|Drug, Route}} | |||
! style="background: #4479BA; width: 350px;" | {{fontcolor|#FFF|Recommended dose}} | |||
! style="background: #4479BA; width: 350px;" | {{fontcolor|#FFF|Duration}} | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" | '''Penicillin V, oral''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*Children: 250 mg twice daily or 3 times daily; adolescents and adults: 250 mg 4 times daily or 500 mg twice daily | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*10 days | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" |'''Amoxicillin, oral''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*50 mg/kg once daily (max = 1000 mg); | |||
*Alternate:25 mg/kg (max = 500 mg) twice daily | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*10 days | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" |'''Benzathine penicillin G, intramuscular''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*<27 kg: 600 000 U; ≥27 kg: 1 200 000 U | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*1 dose | |||
|- | |||
| colspan="3" style="background: #4479BA; text-align: center;" | {{fontcolor|#FFF|'''For individuals with penicillin allergy'''}} | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" | '''Cephalexin, oral''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*20 mg/kg/dose twice daily (max = 500 mg/dose) | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*10 days | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" | '''Cefadroxil, oral''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*30 mg/kg once daily (max = 1 g) | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*10 days | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" | '''Clindamycin, oral''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*7 mg/kg/dose 3 times daily (max = 300 mg/dose) | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*10 days | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" | '''Azithromycin, oral''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*12 mg/kg once daily (max = 500 mg) | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*5 days | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" | '''Clarithromycin, oral''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*7.5 mg/kg/dose twice daily (max = 250 mg/dose) | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*10 days | |||
|- | |||
|} |
Revision as of 19:44, 18 October 2016
Aysha's sandbox
Common complications
Common complications | ||
Pathogen | Complications | |
---|---|---|
Group A Streptococcus |
Suppurative complications
Non suppurative complications
| |
Influenza |
| |
Adenovirus |
| |
Cocksackie A virus |
| |
Ebstein barr virus |
| |
Less common complications | ||
Gonococcus |
| |
Diphtheria |
| |
Heamophilis influenza | ||
Fusobacterium necrophorum | ||
Parainfluenza virus |
|
Pathogen | Complications |
---|---|
Diphtheria |
|
Gonococcus |
|
' |
|
Cocksackie A virus |
|
Ebstein barr virus |
|
Gonococcus |
|
HIV |
|
MRI syphilis 17628376
Among women the median prevalence of genital warts was 1.1% (range 0.8 to 2.3) across all jurisdictions, compared to 4.0% (range 2.9 to 4.7) for MSM and 4.9% (range 3.3 to 5.5) for MSW.
For individuals without penicillin allergy | ||
Drug, Route | Recommended dose | Duration |
---|---|---|
Penicillin V, oral |
|
|
Amoxicillin, oral |
|
|
Benzathine penicillin G, intramuscular |
|
|
For individuals with penicillin allergy | ||
Cephalexin, oral |
|
|
Cefadroxil, oral |
|
|
Clindamycin, oral |
|
|
Azithromycin, oral |
|
|
Clarithromycin, oral |
|
|